NCT00972517View on ClinicalTrials.gov

Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Children

PHASE3CompletedINTERVENTIONAL
Enrollment

245

Participants

Timeline

Start Date

September 29, 2009

Primary Completion Date

November 22, 2010

Study Completion Date

November 22, 2010

Conditions
Influenza
Interventions
BIOLOGICAL

GSK investigational vaccine GSK2340272A

Three intramuscular injections

Trial Locations (8)

67227

GSK Investigational Site, Frankenthal

67547

GSK Investigational Site, Worms

70469

GSK Investigational Site, Stuttgart

74523

GSK Investigational Site, Schwäbisch Hall

77694

GSK Investigational Site, Kehl

81241

GSK Investigational Site, Munich

86720

GSK Investigational Site, Nördlingen

95463

GSK Investigational Site, Bindlach

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00972517 - Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Children | Biotech Hunter | Biotech Hunter